Skip to content
10-Q

Quarterly Report

Senti Biosciences Holdings, Inc. SNTI

0001628280-25-052125

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 26.29M sh
Shares Diluted Q3 2025 · Sep 30, 2025 26.23M sh
Shares Diluted Q3 2025 · Sep 30, 2025 20.83M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.58M sh
Shares Diluted Q3 2025 · Sep 30, 2024 4.57M sh
Capex Q3 2025 · Sep 30, 2025 $196K
Capex Q3 2025 · Sep 30, 2024 $15K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$36.57M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$27.89M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $12.24M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $48.28M
Stockholders Equity Q3 2025 · Sep 30, 2025 $8.12M
Stockholders Equity Q3 2025 · Jun 30, 2025 $24.65M
Stockholders Equity Q3 2025 · Mar 31, 2025 $37.86M
Stockholders Equity Q3 2025 · Dec 31, 2024 $25.65M
Stockholders Equity Q3 2025 · Sep 30, 2024 $15.99M
Stockholders Equity Q3 2025 · Jun 30, 2024 $44.15M
Stockholders Equity Q3 2025 · Mar 31, 2024 $56.09M
Stockholders Equity Q3 2025 · Dec 31, 2023 $66.91M
Current Liabilities Q3 2025 · Sep 30, 2025 $12.03M
Current Liabilities Q3 2025 · Dec 31, 2024 $13.15M
Total Liabilities Q3 2025 · Sep 30, 2025 $44.56M
Total Liabilities Q3 2025 · Dec 31, 2024 $47.09M
Current Assets Q3 2025 · Sep 30, 2025 $18.16M
Current Assets Q3 2025 · Dec 31, 2024 $58.96M
Total Assets Q3 2025 · Sep 30, 2025 $52.69M
Total Assets Q3 2025 · Dec 31, 2024 $97.84M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.69
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.25
Eps Diluted Q3 2025 · Sep 30, 2024 −$6.31
Eps Diluted Q3 2025 · Sep 30, 2024 −$11.41
Eps Basic Q3 2025 · Sep 30, 2025 −$0.69
Eps Basic Q3 2025 · Sep 30, 2025 −$2.25
Eps Basic Q3 2025 · Sep 30, 2024 −$6.31
Eps Basic Q3 2025 · Sep 30, 2024 −$11.41
Sga Expense Q3 2025 · Sep 30, 2025 $6.43M
Sga Expense Q3 2025 · Sep 30, 2025 $20.32M
Sga Expense restated Q3 2025 · Sep 30, 2024 $6.56M
Sga Expense restated Q3 2025 · Sep 30, 2024 $18.29M
Rd Expense Q3 2025 · Sep 30, 2025 $10.52M
Rd Expense Q3 2025 · Sep 30, 2025 $29.83M
Rd Expense Q3 2025 · Sep 30, 2024 $8.66M
Rd Expense Q3 2025 · Sep 30, 2024 $26.58M
Net Income Q3 2025 · Sep 30, 2025 −$18.13M
Net Income Q3 2025 · Sep 30, 2025 −$46.97M
Net Income Q3 2025 · Jun 30, 2025 −$14.73M
Net Income Q3 2025 · Mar 31, 2025 −$14.11M
Net Income Q3 2025 · Sep 30, 2024 −$28.87M
Net Income Q3 2025 · Sep 30, 2024 −$52.18M
Net Income Q3 2025 · Jun 30, 2024 −$11.2M
Net Income Q3 2025 · Mar 31, 2024 −$12.11M
Operating Income Q3 2025 · Sep 30, 2025 −$16.95M
Operating Income Q3 2025 · Sep 30, 2025 −$50.14M
Operating Income Q3 2025 · Sep 30, 2024 −$15.22M
Operating Income Q3 2025 · Sep 30, 2024 −$44.87M